Recommended Pages at pharmalicensing.com
Out-licensing: Adamantyl-OEG-fullerene Hybrids As Potential Therapeutic Agents
pharmalicensing.com — “A series of novel soluble adamantyl-oligoethyleneglycol-fullerene hybrids was prepared via Bingel-Hirsch functionalization of C60 fullerene with various adamantyl-oligoethyleneglycol malonates. As NMDA-targeted antioxidants, these compounds have...” View full resource at pharmalicensing.com
Most Recently Shared on July 28, 2010 at 7:14 pm By:
Adamantyl-OEG-fullerene Hybrids as potential therapeutic agents: A series of novel soluble adamantyl-oligoethylene... http://bit.ly/c6ObMd
Out-licensing: Improving Speech Intelligibility For The Hearing Impaired
pharmalicensing.com — “An improved method for processing audio inputs to hearing impaired, allowing them to better understand speech in a noisy environment.Potential Applications One of the most common complaints among patients with cochlear hearing loss is difficulty in...” View full resource at pharmalicensing.com
Most Recently Shared on July 22, 2010 at 6:41 pm By:
Improving Speech Intelligibility for the Hearing Impaired: An improved method for processing audio inputs to heari... http://bit.ly/9lSlPG
In-licensing: Seeking Pharmaceutical Companies Marketing And Selling Branded Human Therapeutics Or Differentiated Generics In Latin America, Central Asia Or In The Asia Pacific Or Persian Gulf Region, As A Target For Merger Or Acquisition
pharmalicensing.com — “Seeking small to medium sized pharmaceutical companies that are marketing and selling branded human therapeutics or differentiated generics in Latin America, Central Asia or in the Asia Pacific or Persian Gulf region, as a target for merger or acquisition” View full resource at pharmalicensing.com
Most Recently Shared on July 12, 2010 at 11:51 pm By:
Seeking pharmaceutical companies marketing and selling branded human therapeutics or differentiated generics in La... http://bit.ly/czZVZs
Out-licensing: MULTIPOTENTIAL STEM CELLS OBTAINED FROM MAMMAL THYMUS
pharmalicensing.com — “These cells may be used for the treatment and prevention of degenerative and genetic diseases as well as for the treatment of lesions. The cells are also useful in the evaluation of cellular response to biologic or pharmacologic agents.” View full resource at pharmalicensing.com
Most Recently Shared on July 7, 2010 at 10:32 pm By:
MULTIPOTENTIAL STEM CELLS OBTAINED FROM MAMMAL THYMUS: These cells may be used for the treatment and prevention of... http://bit.ly/cvJNWM
Out-licensing: E-MA-07 - A Complete Product Addressing Male Sexual Dysfunction
pharmalicensing.com — “E-MA-07, a clinically proven formula to address all aspects of Male Sexual Dysfunction (MSD). Phase II Clinical Trials showed good efficacy and can be furthur developed as Botanical Drug Product.” View full resource at pharmalicensing.com
Most Recently Shared on June 19, 2010 at 9:04 pm By:
E-MA-07 - A complete product addressing Male Sexual Dysfunction: E-MA-07, a clinically proven formula to address a... http://bit.ly/cytfPN
Out-licensing: Immune Therapy For Treating Mental Disorders
pharmalicensing.com — “A unique immune-based therapy to treat psychological disorders. Psychological disorders (e.g. schizophrenia, depression, etc.) are among the most prevalent diseases of humankind. These disorders affect approximately 16% of the U.S. population aged 18 and.” View full resource at pharmalicensing.com
Most Recently Shared on June 16, 2010 at 8:49 pm By:
Depression Wisdom Active Health Library and OW Health
Immune therapy for treating Mental Disorders: A unique immune-based therapy to treat psychological disorders. Psyc... http://bit.ly/aXHjjC
Out-licensing: Increasing The Efficiency Of Chemotherapy By Modulating The Function Of DNA Polymerase Kappa
pharmalicensing.com — “A method to improve chemotherapy in treating colon cancer patients.Colon cancer is the second leading cause of death from cancer in the United States, with about 112,000 people diagnosed annually. Treatment options may include surgery and/or...” View full resource at pharmalicensing.com
Most Recently Shared on June 14, 2010 at 7:28 pm By:
Increasing the efficiency of Chemotherapy by modulating the function of DNA polymerase kappa: A method to improve ... http://bit.ly/dxKy1Q
Out-licensing: Regulation Of Myelination By Nectin-like Molecules
pharmalicensing.com — “Proteins for treatment of demyelinating disorders.Demyelinating disorders (e.g. multiple sclerosis), i.e. conditions characterized by the destruction of the myelin sheaths of the nerves, are severe diseases that require prolonged hospitalization and may..” View full resource at pharmalicensing.com
Most Recently Shared on June 13, 2010 at 7:15 pm By:
Regulation of Myelination by Nectin-like molecules: Proteins for treatment of demyelinating disorders.Demyelinatin... http://bit.ly/br7kKg
Out-licensing: Treating T-cell Related Inflammatory Conditions By Targeting Runx3
pharmalicensing.com — “Methods for the detection and treatment of chronic inflammatory disorders.Chronic inflammatory diseases afflict millions of people across the world leading to considerable suffering, economic loss and premature death. These diseases include inflammatory..” View full resource at pharmalicensing.com
Most Recently Shared on June 5, 2010 at 12:12 am By:
Inflammatory Bowel Syndrome OW Health
Treating T-cell related inflammatory conditions by targeting Runx3: Methods for the detection and treatment of chr... http://bit.ly/bIN1cK
Out-licensing: Sperm Thermotaxis: Applications To Diagnosis And Treatment Of Infertility
pharmalicensing.com — “Therapy: Enrichment of sperm populations with capacitated spermatozoa by thermotaxis prior infertility treatments (IUI, IVF, ICSI). Diagnostics: The ability of spermatozoa to respond thermotactically may provide a new, more complete diagnostic tool for..” View full resource at pharmalicensing.com
Most Recently Shared on June 1, 2010 at 10:27 pm By:
Sperm Thermotaxis: Applications to Diagnosis and Treatment of Infertility: Therapy: Enrichment of sperm population... http://bit.ly/9seZic
Out-licensing: Repeat Sequences Of The CA125 Gene And Their Use For Diagnostic And Therapeutic Interventions (01-07) DCV
pharmalicensing.com — “Cancer treatment, including vaccines, targets for immune stipulation, drug, or biological modifier delivery” View full resource at pharmalicensing.com
Most Recently Shared on May 18, 2010 at 11:34 pm By:
Repeat Sequences of the CA125 Gene and Their Use for Diagnostic and Therapeutic Interventions (01-07) DCV: Molecul... http://bit.ly/9rsGKb
Out-licensing: Adoptive Immunotherapy For Reestablishing HIV-specific Cytotoxic T-cell (CD8 T-cell) Function In HIV And AIDS Patients And Methods For Assessing The Reestablishment Of CD8 T-cell Function
pharmalicensing.com — “Methods and compositions for rescuing or reestablishing the ability of HIV-specific, cytotoxic T-cells (CD8 T-cells) to proliferate and kill HIV-infected cells such as CD4 cells” View full resource at pharmalicensing.com
Most Recently Shared on May 8, 2010 at 8:55 pm By:
Adoptive Immunotherapy for Reestablishing HIV-specific Cytotoxic T-cell (CD8 T-cell) Function in HIV and AIDS Pati... http://bit.ly/d9S9xn
